What I copied and pasted above are three slides from my upcoming presentations to the 1200 Orthopedic Surgeon attendees at the combined meeting of the Russian Orthopedic Society to be held September 23 and 24 in St Petersburg, Russia. The members will travel from Ukraine, all of Russia including Vladivostok and Siberia, Norway, Estonia, Latvia, Lithuania, Poland, Belarus, Georgia, Azerbaijan, Kazakhstan, and who knows. The mission is orthopedic education and not politics so there are no boarders. As I have previously written, between 2001 and 2007, I had been an invited lecturer and visiting surgeon in more than 37 countries including those listed above. At that time, I was invited to teach hip and knee replacement for arthritis; now I am invited to teach about biologic and regenerative medical means of postponing, perhaps avoidance of a joint replacement for arthritis.

In preparing instructional courses, I continue to expand my knowledge base out of necessity. It is the best continued educational endeavor possible and yet there are no continued medical educational credits for me. In the three slides copied from my talks and pasted above, you will note the code of FDA regulations. No matter our political disagreements, most of the world looks to our FDA for guidance. PRP and Bone Marrow Concentrate are approved while Amniotic Fluid with stem cells is not. Let me now ask the reader a question. How is it possible to advertise “Regenerative Therapy” if Amniotic Fluid actually has living stem cells and such is the case when harvested by amniocentesis when the Federal Code of Regulations prohibits said use as it is drug? If on the other hand, as science indicates, the stem cells in amniotic fluid when fast thawed for injection are killed, how can there be a regenerative possibility in that injectate? Bone Marrow Concentrate has a ten-year clinical scientific basis, I have been clinically documenting outcomes for five.

My next Blog will update you with my experience at the Russian Orthopedic Society meeting, when I return on September 25. If you want an update on how Cellular Orthopedics may help you lessen the pain from osteoarthritis and related joint disease as well as increase your function, call 847-390-7666 to schedule an appointment or watch my webinar: https://sheinkopmd.com/learn-how-regenerative-medicine-may-help-you/

Pin It on Pinterest

Share This
Special Announcement - Now Enrolling for FDA Approved Stem Cell Study
Dr. Mitchell Sheinkop has completed training and is credentialed for the first of its kind FDA approved stem cell clinical trial for knee arthritis. Our clinic is now enrolling patients in this trial. Contact us at 312-767-5761 for details. Click here to learn more.